Welcome to our dedicated page for Carters SEC filings (Ticker: CRI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Carter’s Inc. SEC filings are more than children’s apparel numbers—they disclose the heartbeat of America’s favorite baby brands. Whether you’re comparing wholesale margins to retail store performance or gauging how Asian sourcing affects seasonal inventory builds, every 10-K and 10-Q delivers critical context that can move CRI’s share price.
Stock Titan’s AI turns those dense documents into plain-English intelligence. Need to parse a Carter’s quarterly earnings report 10-Q filing for segment revenue? Our summaries surface it in seconds. Curious about Carter’s insider trading Form 4 transactions before the holiday season? Real-time alerts flag each executive stock move the moment it hits EDGAR. We even translate complex footnotes—so understanding Carter’s SEC documents with AI finally feels effortless.
Here’s what you can explore today:
- Carter’s annual report 10-K simplified—discover holiday inventory strategy, sourcing risk, and brand-licensing royalties.
- Carter’s proxy statement executive compensation—track how leadership pay aligns with same-store sales targets.
- Carter’s 8-K material events explained—from supply-chain disruptions to leadership changes, see why the news matters.
- Carter’s Form 4 insider transactions real-time—monitor buying or selling trends among directors and officers.
Investors regularly ask, “Carter’s SEC filings explained simply?” and “Carter’s earnings report filing analysis?” Now the answers live in one place—updated the instant a document posts. Stop scrolling through 250-page PDFs; start applying AI-powered insight to compare quarter-over-quarter revenue, analyze tariff exposure, and follow Carter’s executive stock transactions Form 4 without delay.
Carter's (NYSE:CRI) director Hali Borenstein filed a Form 4 disclosing the automatic acquisition of 14.8783 common shares on 06/20/2025 at $0.00 per share under the company’s director deferred-compensation program. The dividend-equivalent credit raised her directly held balance to 16,975.0112 shares.
No open-market purchases, sales, or derivative transactions were reported, and the filing contains no other material disclosures or amendments. The transaction appears routine and is not tied to a Rule 10b5-1 trading plan.